HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early outcome after minilaparotomy for the treatment of rectal cancer.

AbstractOBJECTIVE:
To compare early outcomes of the minilaparotomy approach to the resection of rectal cancer with those of conventional laparotomy.
DESIGN:
Retrospective study.
SETTING:
University hospital, Japan.
SUBJECTS:
18 patients who had complete resection through a minilaparotomy and 20 who had a conventional laparotomy served as the study and the control groups, respectively. Patients who were overweight or morbidly obese (body mass index >25) were excluded from the study.
INTERVENTIONS:
Complete resection through a skin incision less than 7 cm in length, or a conventional incision.
MAIN OUTCOME MEASURES:
Early postoperative outcomes.
RESULTS:
Postoperative time intervals to standing, walking, passing flatus, and removal of the urinary catheter, and analgesic requirements were significantly less in the minilaparotomy group (p = 0.007, p = 0.004, p = 0.02, p = 0.002, and p = 0.05, respectively).
CONCLUSIONS:
The minilaparotomy for complete resection of rectal cancer is less invasive than conventional laparotomy, and provides an attractive alternative in highly selected patients who are not overweight.
AuthorsT Nakagoe, T Sawai, T Tsuji, M Jibiki, A Nanashima, H Yamaguchi, T Yasutake, H Ayabe
JournalThe European journal of surgery = Acta chirurgica (Eur J Surg) Vol. 167 Issue 9 Pg. 705-10 (Sep 2001) ISSN: 1102-4151 [Print] England
PMID11759743 (Publication Type: Comparative Study, Journal Article)
Topics
  • Aged
  • Case-Control Studies
  • Female
  • Humans
  • Laparotomy (methods)
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Rectal Neoplasms (surgery)
  • Retrospective Studies
  • Statistics, Nonparametric
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: